Gene · 11214
AKAP13: A-kinase anchoring protein 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. AKAP13: A-kinase anchoring protein 13. Genes, record 11214. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11214
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q12802 | A-kinase anchor protein 13 | 2,813 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents31
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 35877 | Q12802 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 11153 | Q12802 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 11613 | Q12802 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 11613 | Q12802 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 11153 | Q12802 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 619 | Q12802 | Espacenet |
| JP 2025032204 A | 2025-03-11 | 24337 | Q12802 | Espacenet |
| EP 4461818 A2 | 2024-11-13 | 24337 | Q12802 | Espacenet |
| JP 2023123507 A | 2023-09-05 | 270 | Q12802 | Espacenet |
| JP 2023058610 A | 2023-04-25 | 24337 | Q12802 | Espacenet |
1 to 10 of 31
See all 31 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,571
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AKAP13 papers | Newest fiscal year |
|---|---|---|---|
| ZIADK031117 | Development of Drugs Acting at Adenosine Receptors | 12 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| R01DK119192 | Defective PKA Signaling in Cushing's Syndrome | 6 | 2025 |
| ZIADK031115 | Functionalized Congeners of Bioactive Compounds | 6 | 2025 |
| R01DK073368 | Mechanisms of Compartmentalized cAMP Signaling | 5 | 2025 |
| ZIADK031126 | Computer Modeling of G Protein-Coupled Receptors | 5 | 2025 |
| ZIEHD008737 | Reproductive Endocrinology and Infertility Clinical Training Program | 4 | 2025 |
| P20GM130459 | Nevada Center of Biomedical Research Excellence in Molecular and Cellular Signal Transduction in the Cardiovascular System | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 3 | 2025 |
1 to 10 of 1,571Source NIH's project files
See all 1,571 nih grantsPapers1,777
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The molecular geography of cell signaling diseases. | Mol Pharmacol | 2026 | 42735445 | PubTator, text mining | PubMed |
| A-kinase anchoring protein complexes and cAMP signaling within the dorsal root ganglia in chronic pain. | Mol Pharmacol | 2026 | 42664595 | PubTator, text mining | PubMed |
| Glycosylation-Associated Macrophage Signatures Define a Diagnostic Model for Diabetic Retinopathy via Single-Cell Analysis. | J Ophthalmol | 2026 | 42662694 | PubTator, text mining | PubMed |
| Targeted sequencing reveals a distinct genetic alteration landscape in oral multiple primary squamous cell carcinomas. | Arch Oral Biol | 2026 | 42585843 | PubTator, text mining | PubMed |
| AKAP13 regulates GLI1/ULK1 axis and drive tumor resistance to next-generation HER2-targeted therapies. | Oncogene | 2026 | 42562949 | PubTator, text mining | PubMed |
| A genomic framework for tracking antibiotic resistance genes: global dissemination of cfr-family genes. | Antimicrob Agents Chemother | 2026 | 42429792 | PubTator, text mining | PubMed |
| Norepinephrine attenuates acute lung injury by protecting mitochondria via the β2-AR-AKAP1 axis and inhibiting alveolar epithelial pyroptosis. | Redox Biol | 2026 | 42378955 | PubTator, text mining | PubMed |
| Overexpression of miR-219 as a potential therapeutic strategy of glioblastoma cells in vitro. | Sci Rep | 2026 | 42252325 | PubTator, text mining | PubMed |
| Local protein kinase A signaling pathologies in the endocrine system. | Mol Pharmacol | 2026 | 42241862 | PubTator, text mining | PubMed |
| PTK2/FAK inhibition triggers TMED9-mediated protective autophagy in pancreatic cancer cell via enhancing ERGIC-ERES contact. | Autophagy | 2026 | 42144738 | PubTator, text mining | PubMed |
1 to 10 of 1,777
See all 1,777 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11214
GET https://conductscience.org/api/genes/v1/11214/patents?page=2